Basilea Pharmaceutica
BSLN.SW
#6394
Rank
HK$4.43 B
Marketcap
HK$365.95
Share price
-5.97%
Change (1 day)
10.51%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: HK$8.05

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is HK$8.05. In 2023 the company made an earnings per share (EPS) of HK$8.05 a decrease over its 2022 EPS that were of HK$8.58.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023HK$8.05-6.28%
2022HK$8.58-273.94%
2021-HK$4.94-60.87%
2020-HK$12.61-24.46%
2019-HK$16.70-26.92%
2018-HK$22.8459.83%
2017-HK$14.29-63.06%
2016-HK$38.70-19.26%
2015-HK$47.9246.12%
2014-HK$32.8010.07%
2013-HK$29.80-36.76%
2012-HK$47.11-5.42%
2011-HK$49.81-153.36%
2010HK$93.35-198.47%
2009-HK$94.80-15.34%
2008-HK$111.9716.7%
2007-HK$95.9536.07%
2006-HK$70.5179.07%
2005-HK$39.38-46.79%
2004-HK$74.009.83%
2003-HK$67.37-34.23%
2002-HK$102.44